SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-20-086354
Filing Date
2020-07-24
Accepted
2020-07-24 13:00:06
Documents
152

Document Format Files

Seq Description Document Type Size
1 F-1 tm2016252-11_f1.htm F-1 5091166
2 EXHIBIT 3.4 tm2016252d12_ex3-4.htm EX-3.4 25078
3 EXHIBIT 3.5 tm2016252d12_ex3-5.htm EX-3.5 552310
4 EXHIBIT 3.6 tm2016252d12_ex3-6.htm EX-3.6 246400
5 EXHIBIT 3.7 tm2016252d12_ex3-7.htm EX-3.7 58977
6 EXHIBIT 5.1 tm2016252d12_ex5-1.htm EX-5.1 51082
7 EXHIBIT 8.1 tm2016252d12_ex8-1.htm EX-8.1 19516
8 EXHIBIT 8.2 tm2016252d12_ex8-2.htm EX-8.2 19858
9 EXHIBIT 8.3 tm2016252d12_ex8-3.htm EX-8.3 7908
10 EXHIBIT 10.1 tm2016252d12_ex10-1.htm EX-10.1 883665
11 EXHIBIT 10.2 tm2016252d12_ex10-2.htm EX-10.2 268462
12 EXHIBIT 10.3 tm2016252d12_ex10-3.htm EX-10.3 587603
13 EXHIBIT 10.4 tm2016252d12_ex10-4.htm EX-10.4 33192
14 EXHIBIT 10.5 tm2016252d12_ex10-5.htm EX-10.5 42659
15 EXHIBIT 10.6 tm2016252d12_ex10-6.htm EX-10.6 29414
16 EXHIBIT 10.7 tm2016252d12_ex10-7.htm EX-10.7 189719
17 EXHIBIT 10.8 tm2016252d12_ex10-8.htm EX-10.8 96033
18 EXHIBIT 10.9 tm2016252d12_ex10-9.htm EX-10.9 4219015
19 EXHIBIT 10.10 tm2016252d12_ex10-10.htm EX-10.10 14690
20 EXHIBIT 10.11 tm2016252d12_ex10-11.htm EX-10.11 932049
21 EXHIBIT 10.12 tm2016252d12_ex10-12.htm EX-10.12 30748
22 EXHIBIT 10.13 tm2016252d12_ex10-13.htm EX-10.13 212298
23 EXHIBIT 10.14 tm2016252d12_ex10-14.htm EX-10.14 833439
24 EXHIBIT 10.15 tm2016252d12_ex10-15.htm EX-10.15 37870
25 EXHIBIT 10.16 tm2016252d12_ex10-16.htm EX-10.16 52956
26 EXHIBIT 10.17 tm2016252d12_ex10-17.htm EX-10.17 27408
27 EXHIBIT 10.18 tm2016252d12_ex10-18.htm EX-10.18 93486
28 EXHIBIT 10.19 tm2016252d12_ex10-19.htm EX-10.19 133525
29 EXHIBIT 10.20 tm2016252d12_ex10-20.htm EX-10.20 23584
30 EXHIBIT 10.21 tm2016252d12_ex10-21.htm EX-10.21 225169
31 EXHIBIT 10.22 tm2016252d12_ex10-22.htm EX-10.22 112363
32 EXHIBIT 10.23 tm2016252d12_ex10-23.htm EX-10.23 12727
33 EXHIBIT 10.24 tm2016252d12_ex10-24.htm EX-10.24 38834
34 EXHIBIT 10.25 tm2016252d12_ex10-25.htm EX-10.25 47580
35 EXHIBIT 10.26 tm2016252d12_ex10-26.htm EX-10.26 27707
36 EXHIBIT 10.27 tm2016252d12_ex10-27.htm EX-10.27 116814
37 EXHIBIT 10.28 tm2016252d12_ex10-28.htm EX-10.28 197716
38 EXHIBIT 10.29 tm2016252d12_ex10-29.htm EX-10.29 201955
39 EXHIBIT 10.30 tm2016252d12_ex10-30.htm EX-10.30 42362
40 EXHIBIT 10.31 tm2016252d12_ex10-31.htm EX-10.31 6311
41 EXHIBIT 10.32 tm2016252d12_ex10-32.htm EX-10.32 18115
42 EXHIBIT 10.33 tm2016252d12_ex10-33.htm EX-10.33 882728
43 EXHIBIT 10.34 tm2016252d12_ex10-34.htm EX-10.34 19126
44 EXHIBIT 21.1 tm2016252d12_ex21-1.htm EX-21.1 3863
45 EXHIBIT 23.1 tm2016252d12_ex23-1.htm EX-23.1 3464
46 EXHIBIT 99.1 tm2016252d12_ex99-1.htm EX-99.1 2705
47 EXHIBIT 99.2 tm2016252d12_ex99-2.htm EX-99.2 2724
48 EXHIBIT 99.3 tm2016252d12_ex99-3.htm EX-99.3 2865
49 EXHIBIT 99.4 tm2016252d12_ex99-4.htm EX-99.4 2615
50 EXHIBIT 99.5 tm2016252d12_ex99-5.htm EX-99.5 2697
51 EXHIBIT 99.6 tm2016252d12_ex99-6.htm EX-99.6 2736
52 EXHIBIT 99.7 tm2016252d12_ex99-7.htm EX-99.7 2700
53 EXHIBIT 99.8 tm2016252d12_ex99-8.htm EX-99.8 2621
54 EXHIBIT 99.9 tm2016252d12_ex99-9.htm EX-99.9 2532
55 EXHIBIT 99.10 tm2016252d12_ex99-10.htm EX-99.10 3485
56 EXHIBIT 99.11 tm2016252d12_ex99-11.htm EX-99.11 3383
57 GRAPHIC lg_curevacfpo-4clr.jpg GRAPHIC 40504
58 GRAPHIC tm2016252d6-fc_product4clr.jpg GRAPHIC 163875
59 GRAPHIC tm2016252d6_riderbofa42820.jpg GRAPHIC 387706
60 GRAPHIC tm2016252d6_fc-transfpo4c.jpg GRAPHIC 512034
61 GRAPHIC tm2016252d6_fc-bodyfpo4c.jpg GRAPHIC 394911
62 GRAPHIC tm2016252d6_fc-rnaooptfpo.jpg GRAPHIC 188317
63 GRAPHIC tm2016252d6_fc-exploongfpo.jpg GRAPHIC 223595
64 GRAPHIC tm2016252d6_lc-halffpo4c.jpg GRAPHIC 496744
65 GRAPHIC tm2016252d6_lc-half2fpo4c.jpg GRAPHIC 148797
66 GRAPHIC tm2016252d6_lc-prodesfpo4c.jpg GRAPHIC 103023
67 GRAPHIC tm2016252d6_fc-prodesfpo4c.jpg GRAPHIC 188729
68 GRAPHIC tm2016252d6_lc-modimfpo4c.jpg GRAPHIC 125271
69 GRAPHIC tm2016252d6_fc-sequence4c.jpg GRAPHIC 167979
70 GRAPHIC tm2016252d6-mrna.jpg GRAPHIC 161398
71 GRAPHIC tm2016252d6_bc-activfpo4c.jpg GRAPHIC 229630
72 GRAPHIC tm2016252d6-successive.jpg GRAPHIC 274950
73 GRAPHIC tm2016252d6_bc-optutrfpo4c.jpg GRAPHIC 117502
74 GRAPHIC tm2016252d6_bc-optorffpo4c.jpg GRAPHIC 160928
75 GRAPHIC tm2016252d6_bc-opt3endfpo4c.jpg GRAPHIC 137075
76 GRAPHIC tm2016252d6-diverse.jpg GRAPHIC 218699
77 GRAPHIC tm2016252d6_sc-vaclpnfpo.jpg GRAPHIC 303470
78 GRAPHIC tm2016252d6_sc-cvcmfpo4c.jpg GRAPHIC 179561
79 GRAPHIC tm2016252d6-cvcm.jpg GRAPHIC 135676
80 GRAPHIC tm2016252d6-production.jpg GRAPHIC 127751
81 GRAPHIC tm2016252d6_ph-buildfpo4c.jpg GRAPHIC 2379805
82 GRAPHIC tm2016252d6_ph-curevac4clr.jpg GRAPHIC 1604041
83 GRAPHIC tm2016252d6-ph_tumor4clr.jpg GRAPHIC 616245
84 GRAPHIC tm2016252d6-tbl_prelim4clr.jpg GRAPHIC 596008
85 GRAPHIC tm2016252d6-fc_cohorts4clr.jpg GRAPHIC 684971
86 GRAPHIC tm2016252d6-tbl_prefer4clr.jpg GRAPHIC 571212
87 GRAPHIC tm2016252d6-bc_prelim4clr.jpg GRAPHIC 2141159
88 GRAPHIC tm2016252d6_ph-melanfpo4c.jpg GRAPHIC 250665
89 GRAPHIC tm2016252d6-ph_lesions4clr.jpg GRAPHIC 279473
90 GRAPHIC tm2016252d6_ph-metafpo4c.jpg GRAPHIC 199853
91 GRAPHIC tm2016252d6_ph-pretrefpo4c.jpg GRAPHIC 130174
92 GRAPHIC tm2016252d6_lc-survfpo4c.jpg GRAPHIC 197463
93 GRAPHIC tm2016252d6_lc-tumorfpo4c.jpg GRAPHIC 152552
94 GRAPHIC tm2016252d6_lc-tumor2fpo4c.jpg GRAPHIC 180661
95 GRAPHIC tm2016252d6_lc-abscofpo4c.jpg GRAPHIC 179721
96 GRAPHIC tm2016252d6_fc-dosek.jpg GRAPHIC 168274
97 GRAPHIC tm2016252-6_riderg42820.jpg GRAPHIC 135900
98 GRAPHIC tm2016252d6-lc_cv72024c.jpg GRAPHIC 483505
99 GRAPHIC tm2016252d6-bc_sars4clr.jpg GRAPHIC 201098
100 GRAPHIC tm2016252d6-bc_induc4clr.jpg GRAPHIC 528620
101 GRAPHIC tm2016252d6-bc_kinet4clr.jpg GRAPHIC 993673
102 GRAPHIC tm2016252-6_riderf42820.jpg GRAPHIC 40922
103 GRAPHIC tm2016252d6_lc-influenfpo4c.jpg GRAPHIC 384598
104 GRAPHIC tm2016252d6_bc-servntfpoo4c.jpg GRAPHIC 317224
105 GRAPHIC tm2016252d6_bc-lungfpoo4c.jpg GRAPHIC 250006
106 GRAPHIC tm2016252d6_fc-liverfpo4c.jpg GRAPHIC 124269
107 GRAPHIC tm2016252d6_sc-25hcfpo4c.jpg GRAPHIC 178879
108 GRAPHIC tm2016252d6_fc-therafpo4c.jpg GRAPHIC 726221
109 GRAPHIC tm2016252d6_lc-aminofpo4c.jpg GRAPHIC 171145
110 GRAPHIC tm2016252d6_ph-ccl4fpo4c.jpg GRAPHIC 551026
111 GRAPHIC tm2016252d6_lc-dfpo4c.jpg GRAPHIC 74949
112 GRAPHIC tm2016252d6_lc-gfpo4c.jpg GRAPHIC 83627
113 GRAPHIC tm2016252d6_lc-rituxfpo4c.jpg GRAPHIC 115145
114 GRAPHIC tm2016252d6_fc-retinafpo4c.jpg GRAPHIC 277281
115 GRAPHIC tm2016252d6_sc-areabuff.jpg GRAPHIC 636142
116 GRAPHIC tm2016252d6_bc-levelsfpo4c.jpg GRAPHIC 185529
117 GRAPHIC lg_curevac-fpo.jpg GRAPHIC 79401
118 GRAPHIC tm2016252d8_ex3-7img001.jpg GRAPHIC 1655
119 GRAPHIC tm2016252d4_ex5-1img1.jpg GRAPHIC 9243
120 GRAPHIC tm2016252d4_ex5-1img01.jpg GRAPHIC 5285
121 GRAPHIC tm2016252d4_ex8-1img01.jpg GRAPHIC 9243
122 GRAPHIC tm2016252d8_ex8-2img002.jpg GRAPHIC 4713
123 GRAPHIC tm2016252d8_ex8-2img001.jpg GRAPHIC 10182
124 GRAPHIC tm2016252d8_ex8-2img003.jpg GRAPHIC 2719
125 GRAPHIC tm2016252d8_ex8-3img001.jpg GRAPHIC 13914
126 GRAPHIC tm2016252d5_ex10-1img01.jpg GRAPHIC 8079
127 GRAPHIC tm2016252d4_ex10-2img003.jpg GRAPHIC 10163
128 GRAPHIC tm2016252d8_ex10-9img007.jpg GRAPHIC 10163
129 GRAPHIC tm2016252d4_ex10-2img001.jpg GRAPHIC 2155
130 GRAPHIC tm2016252d4_ex10-2img004.jpg GRAPHIC 1035
131 GRAPHIC tm2016252d4_ex10-2img002.jpg GRAPHIC 41665
132 GRAPHIC tm2016252d4_ex10-7img001.jpg GRAPHIC 10529
133 GRAPHIC tm2016252d4_ex10-21img002.jpg GRAPHIC 945
134 GRAPHIC tm2016252d4_ex10-21img001.jpg GRAPHIC 1079
135 GRAPHIC tm2016252d4_ex10-21img003.jpg GRAPHIC 865
136 GRAPHIC tm2016252d4_ex10-21img004.jpg GRAPHIC 875
137 GRAPHIC tm2016252d4_ex10-21img005.jpg GRAPHIC 1164
138 GRAPHIC tm2016252d4_ex10-21img006.jpg GRAPHIC 830
139 GRAPHIC tm2016252d4_ex10-21img007.jpg GRAPHIC 1451
140 GRAPHIC tm2016252d4_ex10-21img008.jpg GRAPHIC 2736
141 GRAPHIC tm2016252d4_ex10-21img009.jpg GRAPHIC 1944
142 GRAPHIC tm2016252d4_ex10-21img010.jpg GRAPHIC 1050
143 GRAPHIC tm2016252d4_ex10-21img011.jpg GRAPHIC 2738
144 GRAPHIC tm2016252d4_ex10-21img012.jpg GRAPHIC 1049
145 GRAPHIC tm2016252d4_ex10-21img013.jpg GRAPHIC 1049
146 GRAPHIC tm2016252d4_ex10-21img014.jpg GRAPHIC 2732
147 GRAPHIC tm2016252d4_ex10-21img015.jpg GRAPHIC 2743
148 GRAPHIC tm2016252d4_ex10-24img001.jpg GRAPHIC 12798
149 GRAPHIC tm2016252d7_ex10-27img001.jpg GRAPHIC 1790
150 GRAPHIC tm2016252d7_ex10-28img001.jpg GRAPHIC 4457
151 GRAPHIC tm2016252d7_ex10-33img001.jpg GRAPHIC 9223
152 GRAPHIC tm2016252d7_ex10-33img002.jpg GRAPHIC 9798
  Complete submission text file 0001104659-20-086354.txt   47057461
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac B.V. (Filer) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-240076 | Film No.: 201046028
SIC: 2834 Pharmaceutical Preparations